Market Cap$121.20B
P/E25.25x
PEG Ratio1.70
Div yield3.50%
Beta0.59
MDT Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-2.38%
Price vs S&P 500 (4W)4.59%
PEG Ratio1.70
VGM Score62.52
P/E Ratio (Annual)25.25x
Indicated Dividend Yield (Annual)3.50%
MDT Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $1.39 | $1.45 | +4.51%(+$0.06) | |
| Q1 2026 | $1.54 | $1.55 | +0.56%(+$0.01) | |
| Q4 2025 | $1.34 | $1.36 | +1.86%(+$0.02) | |
| Q3 2025 | $1.31 | $1.36 | +3.49%(+$0.05) | |
| Q2 2025 | $1.23 | $1.26 | +2.54%(+$0.03) |
MDT Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
3.76
3.84
3.94
3.97
Industry Peers — Electromedical Equipment(31)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
MDTMedtronic plc | B | C | B | 3.2x | 3.8% | 65.7% | 18.1% | $94.75 |
| ITGRInteger Holdings Corporation | C | C | A | 2.3x | 11.6% | 26.1% | 9.7% | $126.70 |
| LIVNLivaNova PLC Ordinary Shares | C | B | B | 2.9x | 8.2% | 68.1% | 12.5% | $77.58 |
| TMDXTransMedics Group, Inc. Common Stock | C | B | D | 3.7x | 88.2% | 58.7% | 12.2% | $70.78 |
| AXGNAxogen, Inc. Common Stock | F | B | B | 8.1x | 14.9% | 74.6% | -11.8% | $34.62 |
| BLFSBioLife Solutions Inc. | F | C | A | 18.4x | 14.9% | 63.9% | 2.9% | $38.61 |
| CNMDCONMED Corporation | B | C | B | 1.0x | 9.8% | 55.8% | 8.0% | $46.72 |
| CBLLCeriBell, Inc. Common Stock | F | A | A | 9.4x | — | 88.9% | -68.6% | $25.04 |
| INMDInMode Ltd. Ordinary Shares | A | D | C | 2.2x | 12.4% | 76.5% | 18.5% | $14.16 |
| CVCapsoVision, Inc. Common Stock | F | D | B | 25.0x | — | 50.9% | -217.1% | $6.53 |
| ELMDElectromed, Inc. | C | B | C | 3.1x | 15.6% | 78.5% | 18.8% | $27.42 |
About Medtronic plc
Medtronic is one of the world's largest medical device manufacturers, offering a diversified portfolio of therapeutic devices for chronic diseases including cardiac, spinal, neurovascular, and surgical applications. The company's product lines span pacemakers and defibrillators, transcatheter heart valves, spinal fixation systems, ablation technologies, and advanced surgical tools. It serves healthcare institutions and physicians across the United States, Western Europe, and Japan, with approximately 50% of revenue derived from international markets.